Search clinical trials for: access site

Total 85608 results

Medstar Health Research Institute
Cardinal Health

Completed

The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure

Cardiac Diagnostic Procedure | Cardiac Interventional Procedure | Femoral Access Site Closure

United States
Aultman Health Foundation

Completed

Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention (TNT-RASP)

Coronary Artery Disease | Angina | Radial Artery Spasm

United States
Memorial Sloan Kettering Cancer Center

Completed

Continued Access to RXDX-105

Ovarian Cancer | Non Small Cell Lung Cancer | RET Gene Mutation | BRAF Gene Mutation

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Dolutegravir Expanded Access Study (DEAP)

HIV Infections | Infection, Human Immunodeficiency Virus

France, Germany, United States, Canada, Belgium, Austria, Brazil, Italy, Poland
AVEO Pharmaceuticals, Inc.

Terminated

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Solid Tumors

United States, Canada, Netherlands, India, Russian Federation, Ukraine
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma

Hepatocellular Carcinoma | Metastasis | Invasion

Taiwan
Impatients N.V. trading as myTomorrows
Immodulon Therapeutics Ltd

No longer available

Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Cancer Stage IV | Pancreas Cancer | Pancreatic Cancer Stage III

France, United Kingdom
General Hospital Groeninge

Completed

Central Venous Access Device Removal in Cancer Patients

Oncology | Haematological Malignancy

Belgium
Institut Paoli-Calmettes

Unknown

An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect Application (ADN-CO)

Solid Tumor | Hematologic Malignancy
Kliniken Essen-Mitte
German Breast Group

Completed

Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer

Early-Stage Breast Carcinoma

Germany, Switzerland
Jazz Pharmaceuticals

Approved for marketing

A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA

Small Cell Lung Cancer
Eli Lilly and Company

Completed

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Australia, Netherlands, Poland, Belgium, France, Hungary, Lithuania, Canada, Czechia, Denmark, Georgia, Japan, Moldova, Republic of, Romania, United Kingdom
Eli Lilly and Company

Completed

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis (COAST-W)

Spondyloarthritis

Italy, Japan, United States, Puerto Rico, Spain, Mexico, Netherlands, France, Poland, Israel, Argentina, Brazil, Canada, Korea, Republic of, Germany, Finland, United Kingdom
University Hospital Muenster

Unknown

Evaluation of Endorings-2-assisted Colonoscopy: a New Accessory for Improvement of Adenoma Detection Rate? (Endorings-2)

Colonic Polyp | Colonic Neoplasms | Colonoscopy | Colonic Adenoma

Germany
Shanghai Zhongshan Hospital

Unknown

Intensive Monitoring and Preemptive Intervention in the Maintenance of AVF

Vascular Access Complication | Vascular Access Site Occlusion | Vascular Access Malfunction
University of Alberta

Completed

Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection (ESSAN)

Shoulder Pain | Head Neck Cancer

Canada
AstraZeneca

Approved for marketing

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

NF type1 With Inoperable Plexiform Neurofibromas

United States
Central Hospital, Nancy, France

Unknown

Conversational Hypnosis for Peripherical Veinous Access (HYPNACESS) (HYPNACESS)

Vascular Access Site Pain

France
University of Aarhus

Completed

A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer

Ovarian Cancer

Denmark
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PRONTO-T2D)

Type 2 Diabetes Mellitus

United States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
Eli Lilly and Company

Completed

A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis (COAST-X)

Axial Spondyloarthritis

United States, Puerto Rico, Russian Federation, Mexico, Poland, Argentina, Austria, Brazil, Canada, Czechia, Finland, Germany, Japan, Korea, Republic of, Netherlands, Romania
BELEN RUIZ-ANTORAN

Completed

Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine (KNOWHER)

Breast Neoplasms

Spain
Eli Lilly and Company
ARMO BioSciences

No longer available

An Expanded Access Program for AM0010 (Pegilodecakin)

Melanoma | Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung Carcinoma | Solid Tumors | Colorectal Carcinoma | Pancreatic Carcinoma
Seagen Inc.

No longer available

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer
InSeal Medical Ltd.

Completed

InSeal VCD Large Bore Vascular Closure Device Safety and Effectiveness Clinical Study (InSealVCD)

Percutaneous Closure of Artery Access Sites

Israel
AstraZeneca
Amgen

Completed

A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult Subjects (PATH-BRIDGE)

Asthma

Germany
Global Isotopes, LLC d/b/a Zevacor Molecular

Completed

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

Metastatic Prostate Cancer

United States
Novartis Pharmaceuticals

Completed

Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator

Hematologic Neoplasms

Israel, United States, Netherlands, Spain
GlaxoSmithKline

Completed

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Asthma

United States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Czechia, Italy, United Kingdom
AstraZeneca
Eli Lilly and Company

Terminated

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia (DAYBREAK-ALZ)

Alzheimer's Disease

United States, Spain, Korea, Republic of, Italy, Portugal, China, Taiwan, Czechia, Japan, Poland, France, Netherlands, United Kingdom, Germany, Russian Federation, Canada, Mexico, Denmark
National University, Singapore
National Cancer Centre, Singapore

Unknown

Accessible Cancer Care to Enable Support for Survivors Programme (ACCESS)

Breast Cancer | Gynecologic Cancer | Survivorship

Singapore
Ipsen

Terminated

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients (POSEIDON)

Prostate Cancer

Italy
Eli Lilly and Company

Completed

A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis (COAST-V)

Spondyloarthritis

Taiwan, United States, Korea, Republic of, Germany, Czechia, Japan, Netherlands
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Component and Couple Analysis of Cancer Communications

Breast Cancer

United States
University of Wisconsin, Madison
M.D. Anderson Cancer Center; National Cancer Institute (NCI); University of Illinois... and other collaborators

Completed

Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

Lung Cancer, Stage IIIb or IV

United States
Pfizer

No longer available

Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive

Non Small Cell Lung Cancer ALK Positive or ROS1 Positive

United States
Universitätsmedizin Mannheim

Completed

Femoral Closure Versus Radial Compression Devices Related to Percutaneous Coronary Interventions Study (FERARI)

Percutaneous Coronary Intervention (PCI) | Arterial Closure Device | Access Site Bleeding | Adverse Cardiac Events

Germany
Amgen

No longer available

Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma

Unresected Stage IIIB to IVM1c Melanoma

Switzerland
Eli Lilly and Company

Terminated

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease (ExpeditionPRO)

Alzheimer's Disease

Italy, United States, Spain, Taiwan, France, Japan, Puerto Rico, Poland, Sweden, Finland, Canada, United Kingdom, Germany
The University of Hong Kong

Unknown

Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men

Prostatic Hyperplasia | Prostate Cancer

Hong Kong
Amgen

Completed

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

Bone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer

Spain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama
AbbVie

No longer available

Expanded Access to Rovalpituzumab Tesirine

Small Cell Lung Cancer
Novartis Pharmaceuticals

No longer available

A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation

Organ Transplantation

United States, Italy, Spain, United Kingdom, Germany, Taiwan, Belgium, Australia, Czechia, France, Switzerland, Norway, Canada, Brazil, Puerto Rico, Russian Federation, New Zealand, Poland, South Africa
Ottawa Hospital Research Institute

Completed

Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment. (OTT 15-06)

Cancer | Breast Cancer

Canada
Ottawa Hospital Research Institute

Completed

REaCT-vascular Access Her2 Negative Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without Trastuzumab (OTT 15-07)

Cancer | Breast Cancer

Canada
Ohio State University Comprehensive Cancer Center
Riverside Methodist Hospital

Completed

Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery

Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Pfizer

No longer available

Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy (AML)

CD33 Positive Acute Myelogenous Leukemia

United States
AstraZeneca
Parexel

Completed

Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers

Chronic Obstructive Pulmonary Disease | Asthma

Germany
AstraZeneca
Quintiles, Inc.

Completed

AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies

Solid Tumors

United States, France, United Kingdom, Netherlands
European Organisation for Research and Treatment...

Withdrawn

SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access (SPECTAbrain)

Brain Neoplasms

France

Search clinical trials for: access site

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations